 | Up a level |
Journal Article
Al-Batran, Salah-Eddin, Hofheinz, Ralf Dieter, Schmalenberg, Harald, Strumberg, Dirk, Goekkurt, Eray, Angermeier, Stefan, Zander, Thomas, Potenberg, Jochem, Kopp, Hans Georg, Pink, Daniel, Siegler, Gabriele Margareta, Schenk, Michael, De Vita, Ferdinando, Maiello, Evaristo, Gaiser, Timo, Sookthai, Disorn, Bankstahl, Ulli Simone, Pauligk, Claudia, Goetze, Thorsten Oliver and Homann, Nils (2020). Perioperative ramucirumab in combination with FLOT versus FLOT alone for resectable esophagogastric adenocarcinoma (RAMSES/FLOT7): Results of the phase II-portion-A multicenter, randomized phase II/III trial of the German AIO and Italian GOIM. J. Clin. Oncol., 38 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Kunzmann, Volker, Martens, Uwe Marc, Alguel, Hana, Siveke, Jens T., Goekkurt, Eray, Pelzer, Uwe 
ORCID: 0000-0001-9213-2737, Siegler, Gabriele Margareta, Hennes, Elke, Waldschmidt, Dirk, Jakobs, Ralf, Ferenczy, Peter, Keller, Ralph, Boeck, Stefan Hubert, Kullmann, Frank, Kapp, Markus and Germer, Christoph Thomas
(2018).
Secondary resectability in locally advanced pancreatic cancer (LAPC) after nab-paclitaxel/gemcitabine- versus FOLFIRINOX-based induction chemotherapy: Interim results of a randomized phase II AIO trial (NEOLAP).
J. Clin. Oncol., 36 (4).
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755